Multifocal electroretinography as a predictor of maintenance of vision after photodynamic therapy for neovascular age-related macular degeneration

Doc Ophthalmol. 2008 Jan;116(1):13-8. doi: 10.1007/s10633-007-9071-z. Epub 2007 Sep 21.

Abstract

Purpose: To investigate the role of multifocal electroretinography (mfERG) in predicting the outcome of photodynamic therapy (PDT) for neovascular age-related macular degeneration (AMD).

Methods: Participants underwent refraction protocol VA assessment using the ETDRS logMAR chart at 1 m, Contrast Sensitivity (CS) using the Pelli-Robson chart at 1 m, fundus fluorescein angiography (FA) and mfERGs in response to 19 segments. Response to PDT was binary (1 = the loss of less than 15 letters at 12 months, 0 = the loss of 15 letters or more) and was used as the dependent variable for logistic regression analysis.

Results: Logistic regression modelling identified mfERG central segment amplitude, lesion size on FA, VA and CS as predictors of outcome (P = 0.05, 0.02, 0.01, 0.03). The model is stable and has excellent discriminability.

Conclusion: The outcomes of this study are particularly relevant to patients in the UK who are sometimes treated with PDT alone. A larger prospective study would facilitate development of an index to predict outcome of future treatments for AMD.

MeSH terms

  • Aged
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / physiopathology
  • Electroretinography*
  • Female
  • Fluorescein Angiography
  • Humans
  • Macular Degeneration / drug therapy*
  • Macular Degeneration / physiopathology
  • Male
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use
  • Predictive Value of Tests
  • ROC Curve
  • Retina / physiopathology*
  • Sensitivity and Specificity
  • Treatment Outcome
  • Visual Acuity / physiology*

Substances

  • Photosensitizing Agents